PDF) 6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party
Sphingolipid metabolites in inflammatory disease | Nature
Invloed van mesalazine op het thiopurinemetabolisme bij patiënten met inflammatoire darmziekten
Actieve thiopurinemetabolieten bij pediatrische patiënten met inflammatoire darmziekten in remissie: azathioprine monotherapie versus combinatietherapie met TNF-α-blokkers | NPFO
Template KFL 08022022.xlsx
PDF) 6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party
Thiopurine metabolieten bepaling
Pharmaceuticals | Free Full-Text | Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
Andres Yarur (@AndresYarur) / Twitter
COCO maison Fernanda Spiegel | Eijerkamp
Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions | PLOS Pathogens
6-Mercaptopurine
PDF) Thiopurines in inflammatory bowel disease: New strategies for optimization of pharmacotherapy?
Laboratorium benaming:
Azathioprine in bloed
Mapping localization of 21 endogenous proteins in the Golgi apparatus of rodent neurons | Scientific Reports
Aldona Spiegel, MD (@DrAldonaSpiegel) / Twitter
Inleiding De interpretatie van bloedspiegels is niet altijd even ...
6-MMP en 6-TGN° - SKB Winterswijk
Ernstige beenmergtoxiciteit bij het gebruik van thiopurines
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression - PEYRIN‐BIROULET - 2008 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Azathioprine/6-MP/tioguanine + 5-amino- salicylaten 9032
PDF) Thiopurines in inflammatory bowel disease: New strategies for optimization of pharmacotherapy?
Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression - PEYRIN‐BIROULET - 2008 - Alimentary Pharmacology & Therapeutics - Wiley Online Library
Actieve thiopurinemetabolieten bij pediatrische patiënten met inflammatoire darmziekten in remissie: azathioprine monotherapie versus combinatietherapie met TNF-α-blokkers | NPFO
Template KFL 08022022.xlsx
